Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients

Atherosclerosis. 2006 Jan;184(1):233-4. doi: 10.1016/j.atherosclerosis.2005.08.021. Epub 2005 Oct 5.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Fatty Liver / blood
  • Fatty Liver / complications
  • Fatty Liver / drug therapy*
  • Fluorobenzenes / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperlipidemias / blood
  • Hyperlipidemias / complications*
  • Hyperlipidemias / drug therapy
  • Lipids / blood
  • Middle Aged
  • Pyrimidines / therapeutic use*
  • Rosuvastatin Calcium
  • Sulfonamides / therapeutic use*
  • Treatment Outcome

Substances

  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids
  • Pyrimidines
  • Sulfonamides
  • Rosuvastatin Calcium